Greenshoe

AESTHETIC MEDICAL INTERNATIONAL HOLDINGS GROUP LIMITED ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

Retrieved on: 
Friday, October 25, 2019
Financial markets, Finance, Corporate finance, Initial public offering, Haitong Securities, American depositary receipt, ADSS, Haitong International, Greenshoe, Limited liability company

Shenzhen, China, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the Company or AIH), a leading provider of aesthetic medical services in China, today announced the pricing of its initial public offering of 2,500,000 American Depositary Shares (the ADSs), each representing three ordinary shares of the Company, at US$12.00 per ADS for the total offering size of approximately US$30.0 million, assuming the underwriters do not exercise their over-allotment option to purchase additional ADSs.

Key Points: 
  • Shenzhen, China, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the Company or AIH), a leading provider of aesthetic medical services in China, today announced the pricing of its initial public offering of 2,500,000 American Depositary Shares (the ADSs), each representing three ordinary shares of the Company, at US$12.00 per ADS for the total offering size of approximately US$30.0 million, assuming the underwriters do not exercise their over-allotment option to purchase additional ADSs.
  • Cantor Fitzgerald & Co., Haitong International Securities Company Limited and Prime Number Capital, LLC are acting as joint bookrunners of this offering.
  • Maxim Group LLC, Tiger Brokers (NZ) Limited and Valuable Capital Limited are acting as co-managers.
  • Leveraging over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, and general medical services and other aesthetic services.

TherapeuticsMD Announces Pricing of Its Underwritten Public Offering of 26 Million Shares of Common Stock

Retrieved on: 
Friday, October 25, 2019
Health, Consumer, Women, Clinical trials, General Health, Pharmaceutical, Finance, Financial markets, Money, Initial public offering, Corporate finance, Stock market, Actuarial science, Underwriting, Stock, Public offering, Greenshoe

TherapeuticsMD, Inc. (NASDAQ:TXMD) today announced the pricing of its underwritten public offering of 26,000,000 shares of its common stock at a price to the public of $2.75 per share.

Key Points: 
  • TherapeuticsMD, Inc. (NASDAQ:TXMD) today announced the pricing of its underwritten public offering of 26,000,000 shares of its common stock at a price to the public of $2.75 per share.
  • TherapeuticsMD has also granted to the underwriters of the offering a 30-day option to purchase up to an additional 3,900,000 shares of common stock at the public offering price, less the underwriting discount.
  • The gross proceeds to TherapeuticsMD from the offering are expected to be $71.5 million, before deducting underwriting discounts, commissions and other offering expenses payable by TherapeuticsMD, assuming no exercise of the underwriters option to purchase additional shares of common stock.
  • All of the shares in the offering are to be sold by TherapeuticsMD.

Reed’s Inc. Prices Underwritten Public Offering of Common Stock

Retrieved on: 
Wednesday, October 23, 2019
Finance, Money, Financial markets, Initial public offering, Corporate finance, Stock market, Underwriting, Public offering, Stock, Private Securities Litigation Reform Act, Short, Greenshoe

Reeds has also granted to the underwriter a 45-day option to purchase up to an additional 1,750,000 shares of common stock to cover overallotments in connection with the offering.

Key Points: 
  • Reeds has also granted to the underwriter a 45-day option to purchase up to an additional 1,750,000 shares of common stock to cover overallotments in connection with the offering.
  • The offering is expected to close on October 25, 2019, subject to customary closing conditions.
  • This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the proposed public offering and the intended use of proceeds from the offering.
  • The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed.

New Mountain Finance Corporation Announces Pricing of 8,000,000 Shares of Common Stock

Retrieved on: 
Wednesday, October 23, 2019
Professional services, Finance, Finance, Money, Financial economics, Corporate finance, Stock market, Initial public offering, Stock, Offering, Public offering, Greenshoe

New Mountain Finance Corporation (the "Company") (NYSE: NMFC) announced today that it has priced an underwritten offering of 8,000,000 shares of its common stock at a public offering price of $13.25 per share.

Key Points: 
  • New Mountain Finance Corporation (the "Company") (NYSE: NMFC) announced today that it has priced an underwritten offering of 8,000,000 shares of its common stock at a public offering price of $13.25 per share.
  • Certain of the Companys officers and interested directors are purchasing an aggregate 400,000 shares in this offering at the public offering price.
  • The Companys investment adviser, New Mountain Finance Advisers BDC, L.L.C.
  • In connection with the offering, the Company has granted the underwriters for the offering an option to purchase up to an additional 1,200,000 shares of the Company's common stock.

Union Acquisition Corp. II Announces Closing of $200 Million Initial Public Offering

Retrieved on: 
Tuesday, October 22, 2019
Banking, Professional services, Finance, Financial markets, Finance, Corporate finance, Greenshoe, NASDAQ, Initial public offering

Union Acquisition Corp. II (NASDAQ: LATNU) (the Company) announced today that it closed its initial public offering of 20,000,000 units, including 2,500,000 units subject to the underwriters over-allotment option, at $10.00 per unit.

Key Points: 
  • Union Acquisition Corp. II (NASDAQ: LATNU) (the Company) announced today that it closed its initial public offering of 20,000,000 units, including 2,500,000 units subject to the underwriters over-allotment option, at $10.00 per unit.
  • The offering was priced at $10.00 per unit, resulting in gross proceeds of $200,000,000.
  • The Companys units began trading on the Nasdaq Capital Market (Nasdaq) under the symbol LATNU on October 18, 2019.
  • Of the proceeds received from the consummation of the initial public offering and a simultaneous private placement of warrants, $200,000,000 (or $10.00 per unit sold in the public offering) was placed in trust.

ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares

Retrieved on: 
Wednesday, October 16, 2019
Finance, Initial public offering, Money, Financial economics, Stock market, Corporate finance, Actuarial science, Underwriting, Greenshoe, Red herring prospectus

In addition, ProQR has granted the underwriters a 30-day option to purchase up to 1,363,636 additional ordinary shares at the public offering price, less underwriting discounts and commissions.

Key Points: 
  • In addition, ProQR has granted the underwriters a 30-day option to purchase up to 1,363,636 additional ordinary shares at the public offering price, less underwriting discounts and commissions.
  • Gross proceeds from the offering are expected to be approximately $50.0 million, assuming no exercise of the underwriters option to purchase additional shares.
  • These forward-looking statements include, but are not limited to, statements about the completion, timing and size of the offering of ProQRs ordinary shares.
  • There can be no assurance that ProQR will be able to complete the offering on the anticipated terms, or at all.

Atrium Mortgage Investment Corporation Announces $15 Million Public Offering and $10 Million Non-Brokered Private Placement of Common Shares

Retrieved on: 
Tuesday, October 8, 2019
Finance, Economy, Money, Initial public offering, Stock market, Investment, Placement, Private placement, Greenshoe, General Electric

Atrium has also agreed to sell746,300 Shares to an entity controlled by an existing shareholder of Atrium on a non-brokered private placement basis, at the Issue Price, for gross proceeds of approximately $10 million (the Non-Brokered Private Placement).

Key Points: 
  • Atrium has also agreed to sell746,300 Shares to an entity controlled by an existing shareholder of Atrium on a non-brokered private placement basis, at the Issue Price, for gross proceeds of approximately $10 million (the Non-Brokered Private Placement).
  • The Non-Brokered Private Placement is subject to certain approvals and is expected to close concurrently with the closing of the Public Offering.
  • Closing of the Public Offering is not contingent on the closing of the Non-Brokered Private Placement.
  • Atrium will raise gross proceeds of approximately $25 million from the Public Offering and Non-Brokered Private Placement (assuming the over-allotment option in connection with the Public Offering is not exercised).

Fortuna Silver Mines Announces Closing of Convertible Debenture Over-Allotment Option

Retrieved on: 
Tuesday, October 8, 2019
Finance, Economy, Money, Fortuna Silver Mines, Stock market, Initial public offering, Greenshoe, S&P/TSX 60 Index, Debenture, Canadian Imperial Bank of Commerce, Allotment, Fortuna

VANCOUVER, British Columbia, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) (Fortuna or the Company) is pleased to announce the full exercise and closing of the over-allotment option (Over-Allotment Option) granted to CIBC Capital Markets, Scotiabank and BMO Capital Markets (collectively, the Underwriters).

Key Points: 
  • VANCOUVER, British Columbia, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) (Fortuna or the Company) is pleased to announce the full exercise and closing of the over-allotment option (Over-Allotment Option) granted to CIBC Capital Markets, Scotiabank and BMO Capital Markets (collectively, the Underwriters).
  • Pursuant to the exercise of the Over-Allotment Option, Fortuna today issued 6,000 Additional Debentures to the Underwriters at a price of US$1,000 per Additional Debenture for additional gross proceeds to the Company of US$6 million, bringing the total aggregate gross proceeds to Fortuna under the Offering to US$46 million.
  • About Fortuna Silver Mines Inc.
    Fortuna is a growth oriented, precious metals producer focused on mining opportunities in Latin America.
  • The Companys primary assets are the Caylloma silver mine in southern Peru, the San Jose silver-gold mine in Mexico and the Lindero gold project, currently under construction, in Argentina.

Grocery Outlet Holding Corp. Announces Pricing of Secondary Offering of Shares of Common Stock

Retrieved on: 
Friday, October 4, 2019
Financial markets, Finance, Money, Stock market, Corporate finance, Initial public offering, Underwriting, Actuarial science, Stock, Greenshoe

The offering is expected to close on October 8, 2019, subject to customary closing conditions.

Key Points: 
  • The offering is expected to close on October 8, 2019, subject to customary closing conditions.
  • The H&F Investor has granted the underwriters a 30-day option to purchase up to 1,950,000 additional shares of the Companys common stock at the public offering price less the underwriting discount.
  • The Company is not selling any shares of common stock in the offering, will not receive any of the proceeds from the sale and will bear the costs associated with the sale of such shares, other than underwriting discounts and commissions.
  • Grocery Outlet has more than 300 stores in California, Washington, Oregon, Pennsylvania, Idaho and Nevada.

VBI Vaccines Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Retrieved on: 
Thursday, September 26, 2019
Biotechnology, FDA, Health, Other Health, Pharmaceutical, Oncology, Research, Infectious diseases, Science, Clinical trials, Finance, Initial public offering, Money, Economy, Corporate finance, Stock market, Public offering, Underwriting, Greenshoe

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the closing of its previously announced underwritten public offering and the exercise in full of the underwriters option to purchase additional shares.

Key Points: 
  • VBI Vaccines Inc. (Nasdaq: VBIV) (VBI or the Company), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced the closing of its previously announced underwritten public offering and the exercise in full of the underwriters option to purchase additional shares.
  • The gross proceeds from the offering, before deducting the underwriting discounts and commissions and estimated offering expenses payable by VBI, are US$40.3 million.
  • 80,500,000 common shares at a public offering price of US$0.50 per share were issued and sold in this offering, which includes 10,500,000 shares issued upon the exercise of the underwriters option to purchase additional shares.
  • Immediately following the closing of the underwritten public offering, the number of outstanding common shares of the Company is 178,257,199.